Influence of flavonoids on cell cycle phase as analyzed by flow-cytometry

被引:30
作者
Koide, T
Kamei, H
Hashimoto, Y
Kojima, T
Terabe, K
Umeda, T
机构
[1] AICHI GAKUIN UNIV HOSP,DEPT SURG,CHIKUSA KU,NAGOYA,AICHI 464,JAPAN
[2] AICHI GAKUIN UNIV,HLTH RES CTR,NISSHIN,AICHI 37001,JAPAN
[3] AICHI GAKUIN UNIV,SCH DENT,DEPT BIOCHEM,CHIKUSA KU,NAGOYA,AICHI 464,JAPAN
[4] AICHI MED SCH,DEPT SURG 1,NAGAKUTE,AICHI 48011,JAPAN
关键词
flavonoid; anthocyanin; flavonol; chalcone; cell cycle;
D O I
10.1089/cbr.1997.12.111
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Flavonoids were previously reported to have cytostatic activity in vitro and in vivo. In the present study each phase of the cell cycle was observed by flow-cytometry after HCT-15 cells had been cultured with flavonoids for 2 days. In the control group, two peaks were observed on the histogram, the first peak representing double strands of DNA, and the second tetra strands. Chalcone, which is known to be a precursor of all flavonoids, seemed to block the passage from S to G(2) and M phases. Flavonone, which is freely transformed into chalcone in vivo, showed a similar histogram as chalcone. Among the anthocyanins most effective in suppressing the tumor cell growth, cyanin and pelargonidin made a mild rise between the Ist and 2nd peak suggesting block between G(1) and S phase. Delphinidin gave a high percent of cells in G(1) phase, suggesting prolongation of G(1) phase. When quercetin or kaempherol, both of which are flavonols were added to the culture, the second peak rose significantly, indicating a block between G(2) and M phases. Thus, the site of these cytostatic agents seems to differ depending on the kind of flavonoid.
引用
收藏
页码:111 / 115
页数:5
相关论文
共 9 条
[1]  
BRITTON G, 1983, BIOCH NATURAL PIGMEN, P102
[2]  
GRISEBACH H, 1982, BIOSYNTHESIS ANTHOCY, P69
[3]   SUPPRESSION OF TUMOR-CELL GROWTH BY ANTHOCYANINS IN-VITRO [J].
KAMEI, H ;
KOJIMA, T ;
HASEGAWA, M ;
KOIDE, T ;
UMEDA, T ;
YUKAWA, T ;
TERABE, K .
CANCER INVESTIGATION, 1995, 13 (06) :590-594
[4]   Tumor cell growth suppression by chalcone (1,3-diphenyl-2-propen-1-one) [J].
Kamei, H ;
Koide, T ;
Hashimoto, Y ;
Kojima, T ;
Hasegawa, M .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1997, 12 (01) :51-54
[5]  
KAMEI H, 1996, CANCER BIOTHER RADI, P217
[6]  
KAVIEF OK, 1970, VOPR ONKOLM, V16, P60
[7]  
KOIDE T, 1996, CANCER BIOTHER RADI, P273
[8]  
PLOWMAN J, 1986, CANCER TREAT REP, V70, P631
[9]  
SHIMOKORIYAMA M, 1991, FLAVONOID PLANT PIGM, P12